{
    "clinical_study": {
        "@rank": "93903", 
        "arm_group": {
            "arm_group_label": "all enrolled subjects", 
            "description": "Intervention is chest x-ray and CT scan.  The chest x-ray image is read first without computer aided detection (CAD) and then a second time with computer aided detection (CAD) the CT scan is read by one reader.  Subjects are asked to contribute breath and blood samples."
        }, 
        "biospec_descr": {
            "textblock": "Blood draw includes 2 10 mL red top tubes for serum retrieval, and 2 7 mL EDTA tubes for\n      plasma and buffy coat retrieval"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The investigators would like to see if lung cancer screening with chest x-rays,computer\n      aided detection (CAD)and a lose dose CT scan  can detect lung cancer in early stages when it\n      is more responsive to treatment. The investigators would also like to see if early detection\n      will reduce the incidence of symptomatic advanced lung cancer compared to no screening in\n      former and current smokers with or without a family history of lung cancer who are 40-75\n      years old."
        }, 
        "brief_title": "Chest Imaging, Breath, and Biomarkers in a Screening Trial", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": "Lung Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The fight against lung cancer is waged on three major fronts: prevention, detection and\n      treatment.  Our goal is to determine if chest x-rays,computer aided detection (CAD)and a CT\n      scan  can detect disease earlier when treatment is more effective. If we improve the\n      detection of disease, we will see if screening reduces the incidence of symptomatic advanced\n      lung cancer relative to no screening in people at high risk to develop lung cancer."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ages 40-75 years\n\n          -  If ages 40-59, then one of the following criteria needs to be met:\n\n               -  Current or ex-smoker with >25 pack years and a family history of lung\n                  cancer(parent or sibling) OR\n\n               -  current or ex-smoker with > 25 pack years and COPD OR\n\n               -  current or ex-smoker with a > 35 pack year history\n\n          -  If ages 60-75, then one of the following additional criteria needs to be met:\n\n               -  Current or ex-smoker with >25 pack years and a family history of lung cancer\n                  (parent or sibling) OR\n\n               -  Current or ex-smoker with >25 pack years and COPD OR\n\n               -  Current or ex-smoker with a >30 pack year history\n\n          -  Subject is able to return to Cleveland Clinic for annual follow-up screening\n\n          -  Subject is willing to sign a medical release form\n\n        Exclusion Criteria:\n\n          -  Current health requires oxygen\n\n          -  Have had a chest x-ray or CT of the chest within the last 6 months\n\n          -  Previous pneumonectomy\n\n          -  Lobectomy of the lung within the last 5 years\n\n          -  Diagnosed malignancy within the last 5 years, excluding non-melanoma skin cancer,\n             carcinoma in situ of the cervix and localized prostate cancer\n\n          -  A medical condition that would prevent treatment for lung cancer\n\n          -  Within the last 6 weeks, one of the following has occured:\n\n               -  A new cough or chronic cough that has gotten worse\n\n               -  Either new shortness of breath, or any worsening of shortness  of breath\n\n               -  A cough producing blood\n\n               -  Constant chest pain\n\n               -  Respiratory infection, pneumonia, or cold\n\n               -  Unintentional and unexplained weight loss greater than 5% of total body weight"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Primary care physicians or any other physician may refer potential candidates.\n        Additionally, subjects may see marketing materials and contact the research team directly.\n        There is no restriction to the area of residence of subjects."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 10, 2008", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01663155", 
            "org_study_id": "07-455", 
            "secondary_id": [
                "State of Ohio grant", 
                "06-055"
            ]
        }, 
        "intervention": {
            "arm_group_label": "all enrolled subjects", 
            "description": "PA view, low dose CT scan", 
            "intervention_name": "chest x-ray with or without CAD, lose dose CT scan", 
            "intervention_type": "Device", 
            "other_name": [
                "CAD", 
                "computer aided detection"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "lung cancer", 
            "chest x-ray", 
            "CT scan", 
            "computer aided detection (CAD)", 
            "screening", 
            "smokers"
        ], 
        "lastchanged_date": "August 9, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cleveland", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44195"
                }, 
                "name": "Cleveland Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Clinical Trial to Develop Chest Imaging, Breath, and Biomarkers in a Screening Trial", 
        "overall_official": [
            {
                "affiliation": "The Cleveland Clinic", 
                "last_name": "Micheal Phillips, M.D.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Chair of Thoracic Imaging", 
                "last_name": "Moulay Meziane, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The false positive rates of chest x-ray with CAD and chest CT will be compared. The analysis will be based on the study subjects from this prospective study who test positive with chest x-ray and/or CT and who are determined not to have lung cancer during the follow-up period.", 
            "measure": "The sensitivities of chest x-ray with CAD and chest CT", 
            "safety_issue": "No", 
            "time_frame": "March, 2012 for scanning results only"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01663155"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Cleveland Clinic", 
            "investigator_full_name": "Moulay Meziane, MD", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Disease-specific mortality between screening with chest x-ray and CAD versus no screening", 
                "safety_issue": "No", 
                "time_frame": "March, 2013 continued through follow up"
            }, 
            {
                "measure": "All-cause mortality rate between screening with chest x-ray and CAD versus no screening", 
                "safety_issue": "No", 
                "time_frame": "March, 2013"
            }, 
            {
                "measure": "Length of time between randomization and the incidence of symptomatic advanced lung cancer for screened subjects versus controls", 
                "safety_issue": "No", 
                "time_frame": "March, 2013 through follow up"
            }, 
            {
                "measure": "Does lung cancer screening with chest x-rays and computer aided detection (CAD) reduce the incidence of symptomatic advanced lung cancer in a high risk population", 
                "safety_issue": "No", 
                "time_frame": "March, 2013"
            }, 
            {
                "measure": "The quality of life between screening with chest x-ray and CAD versus no screening.", 
                "safety_issue": "No", 
                "time_frame": "March, 2013"
            }
        ], 
        "source": "The Cleveland Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Cleveland Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2008", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}